INTRA-CELLULAR THERAPIES INC (ITCI)

US46116X1019 - Common Stock

72.73  +0.92 (+1.28%)

After market: 72.73 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
464.37M250.30M83.80M22.80M100.00K
Cost Of Goods
33.74M20.40M8.00M1.90MN/A
Gross Profit
430.63M229.90M75.80M20.90MN/A
Operating Expenses
590.01M493.50M361.50M252.10M154.10M
Research and Development
180.14M134.70M88.80M65.80M89.10M
Selling, General, and Administrative Expenses
409.86M358.80M272.60M186.40M64.90M
Operating Income
-159.38M-263.60M-285.70M-231.20M-154.00M
Interest Income/Expense
20.34M7.40M1.60M4.20M6.30M
Income Before Taxes
-139.04M-256.30M-284.10M-227.00M-147.70M
Income Tax
636.00K0.000.000.000.00
Net Income
-139.67M-256.30M-284.10M-227.00M-147.70M
EBITDA
-158.85M-262.94M-285.17M-230.67M-153.52M
 
Per Share Data
EPS Diluted Total Ops
-1.46-2.72-3.50-3.23-2.68
Non GAAP EPS
-1.46-2.72-3.50-3.24-2.68
 
Statistics
Gross Profit Margin
92.73%91.85%90.45%91.67%N/A
Profit Margin
-30.08%-102.40%-339.02%-995.61%-147700.00%
Operating Profit Margin
-34.32%-105.31%-340.93%-1014.04%-154000.00%

All data in USD

Charts